Detailed price information for Redhill Biophrma ADR (RDHL-Q) from The Globe and Mail including charting and trades.
Detailed price information for Redhill Biophrma ADR (RDHL-Q) from The Globe and Mail including charting and trades.
RedHill Biopharma Ltd. (NASDAQ:RDHL) acquired exclusive global commercialization rights to Rebyota and exclusive U.S. commercialization rights to Clenpiq from Ferring Pharmaceuticals. The agreement has an initial 13-year term and automatically renews for successive two-year periods unless either party elects not to renew. RedHill Biopharma Ltd. (NASDAQ:RDHL) paid $12 million upfront, funded from the $18 million […]
--RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced the transformational acquisition of exclusive global and U.S. commercialization rights to Rebyota and Clenpiq, from Ferring Pharmaceuticals, as part of Ferring’ s ongoing strategic refocusing. We have monetized Talicia for $18 million cash upfront, plus $35 million in...
This is the newest page. Registered accounts read further back.